PROCTER & GAMBLE HEALTH L (PGHL) financials

PROCTER & GAMBLE HEALTH L (PGHL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.[1]

Market Cap: ₹8,632Cr.
Current Price: ₹5,200
Stock P/E: 25.9
ROE: 61.9%
ROCE: 83.9%
Book Value: ₹316
Dividend Yield: 2.98%
52W High / Low: ₹6,975/4,700

In Jun 2026, PROCTER & GAMBLE HEALTH L (PGHL) reported sales ₹364 Cr and net profit ₹96 Cr.

Annual TTM: sales ₹1,433 Cr, net profit ₹357 Cr.

Shareholding: Promoters 51.82% (Sep 2026), FIIs 6.43% (Sep 2026), DIIs 12.63% (Sep 2026), Public 29.13% (Sep 2026), No. of Shareholders 50,426% (Sep 2026).

PGHL quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	313	310	311	339	325	374	370	364
Expenses	199	186	230	248	205	263	235	264
Operating Profit	114	123	81	90	120	110	136	100
OPM %	36%	40%	26%	27%	37%	30%	37%	27%
Other Income	3	4	3	4	5	4	4	36
Interest	0	0	0	0	0	0	0	0
Depreciation	6	6	5	5	6	6	6	6
Profit before tax	111	122	79	89	119	109	133	129
Tax %	26%	25%	22%	25%	26%	29%	29%	26%
Net Profit	82	91	61	66	89	78	95	96
EPS in Rs	49.60	54.76	36.86	39.87	53.34	46.74	56.99	57.92
Raw PDF	—	—	—	—	—	—	—	—

PGHL profit and loss (₹ Cr.)
Category	Jun 2020 18m	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025 9m	Mar 2026	TTM
Sales	1,356	1,009	1,114	1,230	1,151	934	1,408	1,433
Expenses	1,037	762	846	905	845	616	949	967
Operating Profit	319	246	268	325	307	319	459	466
OPM %	24%	24%	24%	26%	27%	34%	33%	33%
Other Income	66	18	13	18	-5	10	15	49
Interest	0	1	0	1	1	0	1	1
Depreciation	29	30	27	28	27	17	24	24
Profit before tax	355	233	253	314	273	312	450	490
Tax %	28%	24%	24%	27%	26%	25%	27%	—
Net Profit	254	177	193	229	201	234	327	357
EPS in Rs	153.07	106.51	115.98	138.24	121.08	141.22	196.94	214.99
Dividend Payout %	150%	122%	45%	69%	215%	89%	104%	—

PGHL balance sheet (₹ Cr.)
Category	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Equity Capital	17	17	17	17	17	17	17	17
Reserves	800	890	687	600	734	522	520	508
Borrowings	0	0	8	3	12	10	8	9
Other Liabilities	250	269	275	269	338	247	250	308
Total Liabilities	1,067	1,176	986	888	1,101	794	794	841
Fixed Assets	101	101	104	112	144	128	116	102
CWIP	11	21	39	41	32	6	11	14
Investments	0	0	0	0	0	0	0	0
Other Assets	954	1,053	843	736	925	660	667	726
Total Assets	1,067	1,176	986	888	1,101	794	794	841

PGHL cash flows (₹ Cr.)
Category	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Cash from Operating Activity	—	235	247	170	236	228	169	338
Cash from Investing Activity	—	165	-32	-26	-22	-7	10	1
Cash from Financing Activity	—	-883	-387	-289	-98	-418	-235	-344
Net Cash Flow	—	-483	-172	-145	116	-197	-56	-5
Free Cash Flow	—	212	196	132	198	207	168	323
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	—	106%	128%	87%	100%	102%	78%	96%

PGHL shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%	51.82%
FIIs	7.01%	6.86%	6.99%	7.24%	6.97%	6.20%	6.33%	6.43%
DIIs	14.71%	14.21%	14.15%	13.90%	13.84%	13.67%	12.44%	12.63%
Public	26.47%	27.11%	27.03%	27.05%	27.37%	28.30%	29.41%	29.13%
No. of Shareholders	53,736	53,993	52,478	50,006	49,302	50,883	49,056	50,426

PGHL key ratios
Category	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Debtor Days	30	26	22	27	34	27	57	43
Inventory Days	139	113	138	124	136	120	152	137
Days Payable	106	105	209	185	239	184	239	192
Cash Conversion Cycle	63	34	-49	-34	-69	-37	-30	-13
Working Capital Days	22	23	7	17	15	19	48	30
ROCE %	20%	29%	29%	38%	45%	45%	48%	84%

PGHLUpdated 18 Oct 2026, 20:53

Procter & Gamble Health L

PGHLUpdated 18 Oct 2026, 20:53

Market Cap

₹8,632Cr.

Current Price

₹5,200

High / Low

₹6,975/4,700

Stock P/E

25.9

ROE61.9%

ROCE83.9%

Book Value₹316

Face Value₹10.0

Dividend Yield2.98%

About

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	301	256	5	6	44	32	30	17.96
Sep 2023	305	216	6	6	88	26	66	39.5
Dec 2023	310	208	5	7	100	28	72	43.42
Mar 2024	252	185	2	7	63	26	47	28.05
Jun 2024	284	236	-18	7	23	26	17	10.11
Sep 2024	313	199	3	6	111	26	82	49.6
Dec 2024	310	186	4	6	122	25	91	54.76
Mar 2025	311	230	3	5	79	22	61	36.86
Jun 2025	339	248	4	5	89	25	66	39.87
Sep 2025	325	205	5	6	119	26	89	53.34
Dec 2025	374	263	4	6	109	29	78	46.74
Mar 2026	370	235	4	6	133	29	95	56.99
Jun 2026	364	264	36	6	129	26	96	57.92

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Dec 2015	940	0	855	22	23	83	36	54	32.27
Dec 2016	993	0	877	24	25	115	31	79	47.67
Dec 2017	698	0	621	74	19	132	29	94	56.57
Dec 2018	849	0	701	768	21	895	6	839	505.27
Dec 2019	927	0	723	48	17	234	32	159	95.64
Jun 2020 18m	1356	0	1037	66	29	355	28	254	153.07
Jun 2021	1009	1	762	18	30	233	24	177	106.51
Jun 2022	1114	0	846	13	27	253	24	193	115.98
Jun 2023	1230	1	905	18	28	314	27	229	138.24
Jun 2024	1151	1	845	-5	27	273	26	201	121.08
Mar 2025 9m	934	0	616	10	17	312	25	234	141.22
Mar 2026	1408	1	949	15	24	450	27	327	196.94
TTM	1433	1	967	49	24	490	—	357	214.99

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	51.82%
FIIs	6.43%
DIIs	12.63%
Public	29.13%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	51.82%	7.6%	12.66%	27.92%
Mar 2024	51.82%	6.24%	13.72%	28.22%
Jun 2024	51.82%	6.39%	14.56%	27.24%
Sep 2024	51.82%	6.61%	14.84%	26.74%
Dec 2024	51.82%	7.01%	14.71%	26.47%
Mar 2025	51.82%	6.86%	14.21%	27.11%
Jun 2025	51.82%	6.99%	14.15%	27.03%
Sep 2025	51.82%	7.24%	13.9%	27.05%
Dec 2025	51.82%	6.97%	13.84%	27.37%
Mar 2026	51.82%	6.2%	13.67%	28.3%
Jun 2026	51.82%	6.33%	12.44%	29.41%
Sep 2026	51.82%	6.43%	12.63%	29.13%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Dec 2015	17	575	0	192	784	132	7	42	603	784
Dec 2016	17	647	0	215	879	111	30	28	711	879
Dec 2017	17	717	0	258	991	115	9	70	797	991
Dec 2018	17	1524	0	219	1759	104	17	0	1639	1759
Dec 2019	17	800	0	250	1067	101	11	0	954	1067
Jun 2020	17	890	0	269	1176	101	21	0	1053	1176
Jun 2021	17	687	8	275	986	104	39	0	843	986
Jun 2022	17	600	3	269	888	112	41	0	736	888
Jun 2023	17	734	12	338	1101	144	32	0	925	1101
Jun 2024	17	522	10	247	794	128	6	0	660	794
Mar 2025	17	520	8	250	794	116	11	0	667	794
Mar 2026	17	508	9	308	841	102	14	0	726	841

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Dec 2015	83	-68	-12	4
Dec 2016	107	-75	-15	17
Dec 2017	54	-48	-22	-16
Dec 2018	-130	1270	-30	1109
Dec 2019	—	—	—	—
Jun 2020	235	165	-883	-483
Jun 2021	247	-32	-387	-172
Jun 2022	170	-26	-289	-145
Jun 2023	236	-22	-98	116
Jun 2024	228	-7	-418	-197
Mar 2025	169	10	-235	-56
Mar 2026	338	1	-344	-5

Key ratios

Historical financial ratios

Category	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Debtor Days	49	39	64	28	30	26	22	27	34	27	57	43
Inventory Days	140	145	243	154	139	113	138	124	136	120	152	137
Days Payable	55	67	128	124	106	105	209	185	239	184	239	192
Cash Conversion Cycle	134	118	179	58	63	34	-49	-34	-69	-37	-30	-13
Working Capital Days	69	52	94	42	22	23	7	17	15	19	48	30
ROCE %	15%	18%	16%	78%	20%	29%	29%	38%	45%	45%	48%	84%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of PROCTER & GAMBLE HEALTH L (PGHL)?

The reported market capitalisation for PROCTER & GAMBLE HEALTH L (PGHL) is ₹8,632Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of PGHL?

The current price shown for PROCTER & GAMBLE HEALTH L (PGHL) on Fincrux is ₹5,200 with a 52-week high/low of ₹6,975/4,700.

What is the P/E ratio of PROCTER & GAMBLE HEALTH L (PGHL)?

The stock P/E for PROCTER & GAMBLE HEALTH L (PGHL) is 25.9 on Fincrux, with ROE at 61.9% and ROCE at 83.9%.

What were PGHL latest quarterly results?

For Jun 2026, PROCTER & GAMBLE HEALTH L (PGHL) reported sales ₹364 Cr and net profit ₹96 Cr (figures in ₹ crore unless noted).

What are PGHL annual sales and net profit?

For TTM, PROCTER & GAMBLE HEALTH L (PGHL) shows sales of ₹1,433 Cr and net profit of ₹357 Cr on the Fincrux profit & loss statement.

Who owns PROCTER & GAMBLE HEALTH L (PGHL)?

Latest shareholding for PROCTER & GAMBLE HEALTH L (PGHL) on Fincrux: Promoters 51.82% (Sep 2026), FIIs 6.43% (Sep 2026), DIIs 12.63% (Sep 2026), Public 29.13% (Sep 2026), No. of Shareholders 50,426% (Sep 2026).

Where can I find PROCTER & GAMBLE HEALTH L (PGHL) financials?

PROCTER & GAMBLE HEALTH L (PGHL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show PGHL balance sheet and cash flow?

Yes. The PROCTER & GAMBLE HEALTH L (PGHL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 20:53